[Effectiveness and indications for using immunoregulatory therapy in systemic rheumatic diseases].
D000368:Aged; D000917:Antibody Formation / Q000187:drug effects; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007167:Immunotherapy / Q000379:methods*; D007978:Levamisole / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000008:administration & dosage; D012216:Rheumatic Diseases / Q000276:immunology / Q000628:therapy*; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D007978:Levamisole; D010396:Penicillamine
Effektivnost' i pokazaniia k primeneniiu immunoreguliruiushcheĭ terapii sistemnykh revmaticheskikh zabolevaniĭ.